<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32184376</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1943-3654</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Respiratory care</Title><ISOAbbreviation>Respir Care</ISOAbbreviation></Journal><ArticleTitle>Overnight Pulse Oximetry to Determine Prognostic Factors in Subjects With Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>1128</StartPage><EndPage>1134</EndPage><MedlinePgn>1128-1134</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4187/respcare.07154</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The objective of the current study was to determine whether overnight pulse oximetry in patients with amyotrophic lateral sclerosis is prognostic of the onset of awake respiratory failure and hospital admissions.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was an observational study in a cohort of subjects with amyotrophic lateral sclerosis. The study included subjects with a baseline [Formula: see text] &#x2265; 94% on home overnight pulse oximetry testing. Patients age &#x2265; 80 y and those with comorbidities and with poor short-term prognosis or sleep apnea were excluded. The subjects were classified as nocturnal desaturators according to percentage of sleep time with [Formula: see text] &lt; 90% (T90) &gt; 10%.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 76 subjects were included: 40 men (53%), mean &#xb1; SD age 60 &#xb1; 14.4 y, mean &#xb1; SD body mass index 25.7 &#xb1; 4.60 kg/m<sup>2</sup>, and spinal presentation in 63.2%. After overnight pulse oximetry, 20 subjects (26%) were classified as desaturators and 56 (74%) as non-desaturators. In the first year, the subjects with nocturnal desaturation had respiratory failure more often compared with the subjects without desaturation (35% vs 10.91%; <i>P</i> = .02) and had a higher risk of developing respiratory failure during the course of the study (hazard ratio 2.48; <i>P</i> = .030). The desaturator group also had a higher rate of &#x2265; 1 admission (40% vs 7.3%; <i>P</i> = .01) and a higher likelihood of respiratory-related hospitalization (hazard ratio 2.41; <i>P</i> = .02). Median survival was almost 1 year less if T90 &gt; 10% was observed in the overnight pulse oximetry: 21&#xa0;months versus 32&#xa0;months survival if T90 was &#x2264; 10%.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In subjects with amyotrophic lateral sclerosis, nocturnal desaturation conferred a higher risk of respiratory failure and poorer prognosis. Even in the absence of other clinical criteria, early pulse oximetry should be performed and the need for nocturnal ventilatory support assessed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 by Daedalus Enterprises.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bote</LastName><ForeName>Silvia Mart&#xed;n</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>UGC Neumolog&#xed;a, Hospital Universitario Reina Sof&#xed;a, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Natalia Pascual</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>UGC Neumolog&#xed;a, Hospital Universitario Reina Sof&#xed;a, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Maim&#xf3;nides de Investigaci&#xf3;n Biom&#xe9;dica de C&#xf3;rdoba, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amarilla</LastName><ForeName>Cristina Esteban</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Groupe Hospitalier Piti&#xe9;-Sal&#xea;tri&#xe8;re. Service de Pneumologie et R&#xe9;animation Medicale du D&#xe9;partement R3S, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ugalde</LastName><ForeName>Pilar Font</ForeName><Initials>PF</Initials><AffiliationInfo><Affiliation>Instituto Maim&#xf3;nides de Investigaci&#xf3;n Biom&#xe9;dica de C&#xf3;rdoba, C&#xf3;rdoba, Spain. fougp@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medicine Department, University of C&#xf3;rdoba, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Bermejo</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, INSERM, UMRS 1158, Neurophysiologie Respiratorire Exp&#xe9;rimentale et Clinique, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>AP-HP, Groupe Hospitalier Piti&#xe9;-Sal&#xea;triere Charles Foix, Service de Pneumologie et R&#xe9;animation Medicale du D&#xe9;partement R3S, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collado</LastName><ForeName>Nuria Feu</ForeName><Initials>NF</Initials><AffiliationInfo><Affiliation>UGC Neumolog&#xed;a, Hospital Universitario Reina Sof&#xed;a, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Maim&#xf3;nides de Investigaci&#xf3;n Biom&#xe9;dica de C&#xf3;rdoba, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gamez</LastName><ForeName>Bernabe Jurado</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>UGC Neumolog&#xed;a, Hospital Universitario Reina Sof&#xed;a, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Maim&#xf3;nides de Investigaci&#xf3;n Biom&#xe9;dica de C&#xf3;rdoba, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medicine Department, University of C&#xf3;rdoba, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Respir Care</MedlineTA><NlmUniqueID>7510357</NlmUniqueID><ISSNLinking>0020-1324</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010092" MajorTopicYN="N">Oximetry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017286" MajorTopicYN="N">Polysomnography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">neuromuscular disease</Keyword><Keyword MajorTopicYN="N">noninvasive ventilation</Keyword><Keyword MajorTopicYN="N">overnight pulse oximetry</Keyword><Keyword MajorTopicYN="N">respiratory failure</Keyword><Keyword MajorTopicYN="N">survival</Keyword></KeywordList><CoiStatement>The authors have disclosed no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32184376</ArticleId><ArticleId IdType="doi">10.4187/respcare.07154</ArticleId><ArticleId IdType="pii">respcare.07154</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>